Phaseline

Targets › HTR1F

HTR1F (5-hydroxytryptamine receptor 1F): drug programs, companies and trials

1 program from 1 company in 1 trial: 1 Phase 1; Neurology; next expected readout Dec 2026.

G protein-coupled receptor for 5-hydroxytryptamine (serotonin). Also functions as a receptor for various alkaloids and psychoactive substances. (UniProt, P30939)

Open in Phaseline: the race on HTR1F, likelihood bands and readouts

Programs

CompanyDrugTargetsHighest phaseConditionsNext expected readout
TechnophageEletriptan Hydrobromide
Serotonin 1f (5-HT1f) receptor agonist; Serotonin 1b (5-HT1b) receptor agonist; Serotonin 1d (5-HT1d) receptor agonist
HTR1F, HTR1B, HTR1DPhase 1Acute Spinal Cord Injury (SCI)Dec 2026

Conditions

Acute Spinal Cord Injury (SCI) (1)

Modalities

small molecule (1)

Companies

Technophage (1)

Related targets

HTR1B (1) HTR1D (1)

Programs group each company's trials by drug; targets and mechanisms come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood is in the app.